Lineage Cell Therapeutics, Inc. SEC filings LCTX
Lineage Cell Therapeutics, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Jul 3, 2012. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jun 12, 2026 | Jun 9, 2026 |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| ARS | Annual report to shareholders | Apr 29, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 29, 2026 | — |
| DEF 14A | Proxy statement | Apr 29, 2026 | Apr 29, 2026 |
| EFFECT | Filing | Mar 23, 2026 | — |
| CORRESP | Letter to the SEC | Mar 19, 2026 | — |
| UPLOAD | Letter from the SEC | Mar 16, 2026 | — |
| S-3 | Shelf registration | Mar 11, 2026 | — |
| 8-K |
Current report
Other events
|
Mar 11, 2026 | Mar 11, 2026 |
| 424B5 | Prospectus supplement | Mar 11, 2026 | — |
| 10-K | Annual report | Mar 5, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 5, 2026 | Mar 5, 2026 |
| 8-K |
Current report
Other events
|
Nov 28, 2025 | Nov 28, 2025 |
| 8-K |
Current report
Other events
|
Nov 24, 2025 | Nov 20, 2025 |
| 8-K |
Current report
Other events
|
Nov 12, 2025 | Nov 12, 2025 |
| 424B3 | Prospectus | Nov 12, 2025 | — |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 26, 2025 | Aug 26, 2025 |
| S-8 | Employee stock plan registration | Aug 15, 2025 | — |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jul 2, 2025 | Jun 26, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 23, 2025 | Jun 23, 2025 |
| DEFA14A | Additional proxy material | Jun 11, 2025 | — |
| 8-K |
Current report
Auditor change
|
Jun 9, 2025 | Jun 3, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| 8-K |
Current report
Other events
|
May 1, 2025 | May 1, 2025 |
| ARS | Annual report to shareholders | Apr 29, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 29, 2025 | — |
| DEF 14A | Proxy statement | Apr 29, 2025 | Jun 26, 2025 |
| 10-K | Annual report | Mar 10, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2025 | Mar 10, 2025 |
| 8-K |
Current report
Shareholder vote results, Regulation FD disclosure, Other events
|
Jan 27, 2025 | Jan 27, 2025 |
| DEF 14A | Proxy statement | Dec 9, 2024 | Dec 9, 2024 |
| PRE 14A | Preliminary proxy statement | Nov 29, 2024 | Nov 29, 2024 |
| 424B5 | Prospectus supplement | Nov 21, 2024 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Nov 20, 2024 | Nov 19, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Auditor change
|
Jun 14, 2024 | Jun 11, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 13, 2024 | Jun 11, 2024 |
| EFFECT | Filing | May 14, 2024 | — |
| 8-K |
Current report
Other events
|
May 14, 2024 | May 14, 2024 |
| 424B5 | Prospectus supplement | May 14, 2024 | — |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| ARS | Annual report to shareholders | Apr 29, 2024 | Apr 29, 2024 |
| DEFA14A | Additional proxy material | Apr 29, 2024 | — |
| DEF 14A | Proxy statement | Apr 29, 2024 | Jun 11, 2024 |
| 424B5 | Prospectus supplement | Mar 22, 2024 | — |
| 8-K |
Current report
Material agreement, Other events
|
Mar 22, 2024 | Mar 12, 2024 |
| S-3 | Shelf registration | Mar 7, 2024 | — |
| 10-K | Annual report | Mar 7, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 7, 2024 | Mar 7, 2024 |
| 8-K |
Current report
Other events
|
Feb 15, 2024 | Feb 14, 2024 |
| 424B5 | Prospectus supplement | Feb 6, 2024 | — |
| 8-K |
Current report
Material agreement, Other events
|
Feb 6, 2024 | Feb 6, 2024 |
| 424B5 | Prospectus supplement | Feb 6, 2024 | — |
| S-8 | Employee stock plan registration | Nov 13, 2023 | — |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Sep 7, 2023 | Sep 6, 2023 |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2023 | Aug 10, 2023 |
| ARS | Annual report to shareholders | Jul 27, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Jul 27, 2023 | — |
| DEF 14A | Proxy statement | Jul 27, 2023 | Jul 27, 2023 |
| PRE 14A | Preliminary proxy statement | Jul 11, 2023 | Jul 11, 2023 |
| 8-K |
Current report
Other events
|
Jun 21, 2023 | Jun 21, 2023 |
| 8-K |
Current report
Other events
|
May 18, 2023 | May 18, 2023 |
| 424B5 | Prospectus supplement | May 18, 2023 | — |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| 10-K/A | Amended annual report | Apr 27, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 9, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 9, 2023 | Mar 9, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 23, 2023 | Jan 23, 2023 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Officer or director change
|
Oct 31, 2022 | Oct 28, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 28, 2022 | Oct 26, 2022 |
| 8-K/A |
Amended current report
Officer or director change
|
Sep 30, 2022 | Sep 20, 2022 |
| 8-K |
Current report
Officer or director change
|
Sep 26, 2022 | Sep 20, 2022 |
| 10-Q | Quarterly report | Aug 11, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2022 | Aug 11, 2022 |
| 8-K |
Current report
Officer or director change
|
Jul 7, 2022 | Jul 5, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2022 | Jun 16, 2022 |
| 10-Q | Quarterly report | May 12, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 12, 2022 | May 12, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 12, 2022 | May 11, 2022 |
| DEFA14A | Additional proxy material | Apr 29, 2022 | — |
| DEF 14A | Proxy statement | Apr 29, 2022 | Apr 29, 2022 |
| 10-K | Annual report | Mar 10, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2022 | Mar 10, 2022 |
| 8-K |
Current report
Other events
|
Feb 14, 2022 | Feb 11, 2022 |
| 8-K |
Current report
Other events
|
Dec 21, 2021 | Dec 21, 2021 |
| 424B5 | Prospectus supplement | Dec 21, 2021 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Dec 20, 2021 | Dec 17, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 13, 2021 | Dec 13, 2021 |
| 10-Q | Quarterly report | Nov 10, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2021 | Nov 10, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 30, 2021 | Sep 30, 2021 |
| S-8 | Employee stock plan registration | Sep 28, 2021 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Sep 15, 2021 | Sep 13, 2021 |
| DEFA14A | Additional proxy material | Sep 2, 2021 | — |
| 10-Q | Quarterly report | Aug 12, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2021 | Aug 12, 2021 |
| DEFA14A | Additional proxy material | Aug 3, 2021 | — |
| DEF 14A | Proxy statement | Aug 3, 2021 | Aug 3, 2021 |
| 8-K |
Current report
Auditor change
|
Jul 21, 2021 | Jul 20, 2021 |
| 8-K |
Current report
Officer or director change
|
Jun 16, 2021 | Jun 16, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 1, 2021 | Jun 1, 2021 |
| 10-Q | Quarterly report | May 13, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 13, 2021 | May 13, 2021 |
| 8-K |
Current report
Officer or director change
|
May 5, 2021 | May 4, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 3, 2021 | May 3, 2021 |
| 8-K |
Current report
Officer or director change
|
Apr 22, 2021 | Apr 20, 2021 |
| 8-K |
Current report
Officer or director change
|
Mar 29, 2021 | Mar 29, 2021 |
| 8-K |
Current report
Officer or director change
|
Mar 26, 2021 | Mar 23, 2021 |
| 8-K |
Current report
Other events
|
Mar 23, 2021 | Mar 23, 2021 |
| EFFECT | Filing | Mar 19, 2021 | — |
| EFFECT | Filing | Mar 19, 2021 | — |
| CORRESP | Letter to the SEC | Mar 17, 2021 | — |
| CORRESP | Letter to the SEC | Mar 17, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 16, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 16, 2021 | — |
| S-3 | Shelf registration | Mar 11, 2021 | — |
| S-8 | Employee stock plan registration | Mar 11, 2021 | — |
| S-3 | Shelf registration | Mar 11, 2021 | — |
| 10-K | Annual report | Mar 11, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 11, 2021 | Mar 11, 2021 |
| 8-K |
Current report
Results of operations, Other events
|
Mar 5, 2021 | Mar 5, 2021 |
| 424B5 | Prospectus supplement | Mar 5, 2021 | — |
| 8-K |
Current report
Officer or director change
|
Jan 20, 2021 | Jan 15, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 6, 2021 | Jan 6, 2021 |
| 8-K |
Current report
Other events
|
Nov 16, 2020 | Nov 16, 2020 |
| 8-K |
Current report
Other events
|
Nov 12, 2020 | Nov 11, 2020 |
| 10-Q | Quarterly report | Nov 4, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2020 | Nov 4, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Sep 23, 2020 | Sep 22, 2020 |
| 8-K |
Current report
Agreement ended
|
Sep 14, 2020 | Sep 11, 2020 |
| DEF 14A | Proxy statement | Aug 7, 2020 | Aug 7, 2020 |
| DEFA14A | Additional proxy material | Aug 7, 2020 | — |
| 10-Q | Quarterly report | Aug 6, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2020 | Aug 6, 2020 |
| 8-K |
Current report
Other events
|
May 21, 2020 | May 21, 2020 |
| EFFECT | Filing | May 8, 2020 | — |
| 10-Q | Quarterly report | May 7, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Material agreement, Results of operations
|
May 7, 2020 | May 6, 2020 |
| CORRESP | Letter to the SEC | May 6, 2020 | — |
| UPLOAD | Letter from the SEC | May 6, 2020 | — |
| S-3 | Shelf registration | May 1, 2020 | — |
| 10-K/A | Amended annual report | Apr 28, 2020 | Dec 31, 2019 |
| 10-K | Annual report | Mar 12, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2020 | Mar 12, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2020 | Jan 13, 2020 |
| 10-Q | Quarterly report | Nov 12, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2019 | Nov 12, 2019 |
| 8-K |
Current report
Other events
|
Oct 18, 2019 | Oct 17, 2019 |
| 8-K |
Current report
Other events
|
Oct 15, 2019 | Oct 14, 2019 |
| 8-K |
Current report
Other events
|
Sep 19, 2019 | Sep 19, 2019 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Aug 12, 2019 | Aug 9, 2019 |
| S-8 | Employee stock plan registration | Aug 8, 2019 | — |
| 10-Q | Quarterly report | Aug 8, 2019 | Jun 30, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2019 | Aug 8, 2019 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jul 30, 2019 | Jul 30, 2019 |
| 8-K |
Current report
Officer or director change
|
Jul 5, 2019 | Jul 2, 2019 |
| DEFA14A | Additional proxy material | Jun 14, 2019 | — |
| DEF 14A | Proxy statement | Jun 14, 2019 | Jun 14, 2019 |
| 8-K |
Current report
Other events
|
May 10, 2019 | May 9, 2019 |
| 8-K |
Current report
Results of operations
|
May 9, 2019 | May 9, 2019 |
| 10-Q | Quarterly report | May 9, 2019 | Mar 31, 2019 |
| 8-K |
Current report
Other events
|
May 2, 2019 | May 2, 2019 |
| 10-K/A | Amended annual report | May 1, 2019 | Dec 31, 2018 |
| 10-K/A | Amended annual report | Apr 30, 2019 | Dec 31, 2018 |
| 8-K |
Current report
Other events
|
Apr 29, 2019 | Apr 26, 2019 |
| 8-K/A | Amended current report | Apr 25, 2019 | Mar 8, 2019 |
| 8-K |
Current report
Other events
|
Apr 23, 2019 | Apr 23, 2019 |
| 8-K |
Current report
Other events
|
Mar 19, 2019 | Mar 14, 2019 |
| 8-K |
Current report
Results of operations
|
Mar 14, 2019 | Mar 14, 2019 |
| 10-K | Annual report | Mar 14, 2019 | Dec 31, 2018 |
| 8-K |
Current report
Acquisition or sale of assets, Officer or director change, Shareholder vote results
|
Mar 8, 2019 | Mar 8, 2019 |
| 8-K |
Current report
Other events
|
Mar 1, 2019 | Mar 1, 2019 |
| 425 | Filing | Mar 1, 2019 | — |
| 8-K |
Current report
Officer or director change
|
Feb 22, 2019 | Feb 19, 2019 |
| 8-K |
Current report
Other events
|
Feb 14, 2019 | Feb 14, 2019 |
| 424B3 | Prospectus | Feb 4, 2019 | — |
| S-4/A | Filing | Jan 14, 2019 | — |
| S-4 | Registration for a merger or exchange | Jan 4, 2019 | — |
| 8-K |
Current report
Officer or director change
|
Jan 4, 2019 | Jan 3, 2019 |
| 8-K |
Current report
Officer or director change
|
Dec 20, 2018 | Dec 17, 2018 |
| 425 | Filing | Dec 6, 2018 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- LCTX (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- CA
- Headquarters
- Carlsbad, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 876343
- Former names
- BIOTIME INC (until Aug 8, 2019)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.